School of Integrative Engineering, Chung-Ang University, Seoul, Republic of Korea.
School of Biological Sciences, Chonnam National University, Gwangju, Republic of Korea.
BMC Bioinformatics. 2018 Jun 13;19(Suppl 8):207. doi: 10.1186/s12859-018-2194-2.
Administered drugs are often converted into an ineffective or activated form by enzymes in our body. Conventional in silico prediction approaches focused on therapeutically important enzymes such as CYP450. However, there are more than thousands of different cellular enzymes that potentially convert administered drug into other forms.
We developed an in silico model to predict which of human enzymes including metabolic enzymes as well as CYP450 family can catalyze a given chemical compound. The prediction is based on the chemical and physical similarity between known enzyme substrates and a query chemical compound. Our in silico model was developed using multiple linear regression and the model showed high performance (AUC = 0.896) despite of the large number of enzymes. When evaluated on a test dataset, it also showed significantly high performance (AUC = 0.746). Interestingly, evaluation with literature data showed that our model can be used to predict not only enzymatic reactions but also drug conversion and enzyme inhibition.
Our model was able to predict enzymatic reactions of a query molecule with a high accuracy. This may foster to discover new metabolic routes and to accelerate the computational development of drug candidates by enabling the prediction of the potential conversion of administered drugs into active or inactive forms.
在我们体内,酶常常会将已服用的药物转化为无效或激活的形式。传统的计算预测方法主要针对细胞色素 P450 等治疗上重要的酶。然而,有超过数千种不同的细胞酶可能会将已服用的药物转化为其他形式。
我们开发了一种计算模型,用于预测人类酶(包括代谢酶和 CYP450 家族)中哪些可以催化给定的化学化合物。该预测是基于已知酶底物和查询化学化合物之间的化学和物理相似性。我们的计算模型使用多元线性回归开发,尽管酶的数量众多,但该模型表现出了很高的性能(AUC=0.896)。在测试数据集上进行评估时,它也表现出了显著的高性能(AUC=0.746)。有趣的是,通过文献数据的评估表明,我们的模型不仅可以用于预测酶反应,还可以用于预测药物转化和酶抑制。
我们的模型能够以高精度预测查询分子的酶反应。这可能有助于发现新的代谢途径,并通过预测已服用药物向活性或非活性形式的潜在转化,加速候选药物的计算开发。